Developments in Abortion, Autonomy, and Access:
This week’s Reproductive Health Digest examines the results of last week’s midterm elections and what they mean for the legal landscape around reproductive rights. Reproductive rights were on the ballot in four states, and voters in three of them chose to protect those rights. In Idaho, the ballot measure failed, and the state’s total abortion ban is back in full effect following a ruling from the 9th Circuit Court of Appeals. Beyond the ballot measures, the midterms delivered a political sea change in states across the country. The incoming senators, governors, attorneys general and others will have a significant opportunity to shape reproductive rights and health equity in the years ahead. The Trump administration already appears to be responding to that anticipated change, including by intervening in a lawsuit brought by Texas against Planned Parenthood, which Texas may drop once its new attorney general is sworn in in January. In addition to election results, we discuss promising new research suggesting that the abortion pill may be beneficial for breast cancer treatment, and how abortion bans are hindering that research. As always, please read to the end for the news that you need to know.
Want access to a detailed analysis of the abortion law in every U.S. state and territory? Please view our free Policy Resource Hub for Reproductive Health, an exclusive legal database where we update the state of the law every single day - so you’re always up to speed.
🚨Action Alert: The Trump administration has nominated Jim O’Neillto lead the National Science Foundation, an independent federal agency that directs billions in funding for critical research nationwide and acts as a crucial tool for shaping and protecting public health. O’Neillis not a scientist and his background, including his record of advocating against research-backed vaccination recommendations, raises serious concerns about his fitness for the position. We are calling on our community to demand scrutiny of his appointment. We recommend you submit your comment through the Union of Concerned Scientists action portal.
If you’d rather not receive the bi-weekly Reproductive Health Digest but still want to get other L4GG emails, you can opt out of just this newsletter here.
Legislation & Litigation:
Overview
Four states had abortion on the ballot in last week’s midterms, and Missouri, Nevada, and Virginia voted to protect those rights; unfortunately, Idaho’s measure did not pass, leaving the state’s total abortion ban in place;
The Ninth Circuit Court of Appeals issued an order reinstating Idaho’s total abortion ban while litigation challenging its constitutionality plays out; and
The Trump administration’s DOJ has intervened in Texas’s lawsuit against Planned Parenthood, likely in anticipation of Texas withdrawing from the litigation early next year.
Three of Four States Vote to Protect Reproductive Rights in the Midterm Elections:
Post-Dobbs, ballot measures have emerged as a powerful tool for protecting reproductive rights. When abortion is on the ballot, it succeeds the majority of the time, and this election was no different – of the four states voting on reproductive rights, three voted to protect the right to care. Please read on for a breakdown of the results.
Virginia:
In Virginia, voters approved a constitutional amendment establishing a fundamental right to reproductive freedom, though the measure faces an immediate post-election legal hurdle. The Founding Freedoms Law Center, the legal arm of the conservative Family Foundation of Virginia, is seeking a preliminary injunction from the Tazewell County Circuit Court to halt certification of the election results. A hearing is scheduled for November 13. State officials have defended the General Assembly’s constitutional authority over the amendment process, and unless the court intervenes to halt certification, the amendment is slated to take effect on January 1.
Nevada:
In Nevada, voters passed Question 6 by a comfortable 63-to-37 margin, creating constitutional protections for abortion until fetal viability and throughout pregnancy when necessary to preserve the patient's life or health. Because Nevada requires constitutional amendments to be passed twice before taking effect, this election was the second and final vote, following a similarly successful result in 2024. Although abortion is already legal until 24 weeks gestational age, the constitutional amendment cements those rights, protecting them from future shifts in the state’s political leadership.
Missouri
In Missouri, voters rejected Amendment 3 by roughly 55% of the vote, reaffirming and preserving the pre-viability abortion rights established by citizen-led ballot initiative in 2024. The measure also included a constitutional ban on gender-affirming care for minors.
In addition to rejecting Amendment 3, Missourians approved Amendment 6, which implements a requirement of an 80% supermajority in both legislative chambers for lawmakers to alter or undermine citizen-initiated constitutional amendments. Although anti-abortion Republican leaders are likely to pursue incremental abortion regulations and restrictions in upcoming legislative sessions, abortion rights advocates view the combined ballot results and the end of the GOP legislative supermajority as a decisive defense of reproductive autonomy.
Idaho
In Idaho, a state with one of the nation’s most severe abortion bans, voters rejected a measure that would have protected abortion until fetal viability. If passed, Proposition 1 would not have amended the state constitution. Instead, it would have created a statutory right to reproductive freedom, including pre-viability abortion, contraception, fertility care, and miscarriage management. Although passage appeared to be well within reach, the coalition opposed to Proposition 1 was highly coordinated and extremely well-funded. As discussed in greater detail below, Idaho’s abortion ban is currently being litigated on constitutional grounds and is in full effect as of the time of publication.
Ninth Circuit Issues Ruling Maintaining Idaho Abortion Ban:
Earlier this year, U.S. District Court Judge B. Lynn Winmill issued a decision striking down key provisions of Idaho’s near-total abortion ban. He ruled that, although Dobbs may have found that there is no privacy-based fundamental right to abortion, the Fourteenth Amendment’s due process and equal protection clauses guarantee a right to care when pregnancy poses a serious threat to a patient’s physical health or risk of self-harm. The lawsuit was brought by a maternal-fetal medicine specialist represented by the Lawyering Project and Legal Voice.
Judge Winmill’s ruling, which was later partially narrowed, enjoined state prosecutors from criminally prosecuting the plaintiff for providing abortion care necessary to preserve a patient’s health. Rejecting state arguments that bodily autonomy yields to government mandate, Judge Winmill wrote that a pregnant person’s health is not a state resource to be allocated at the legislature’s whim. Idaho immediately appealed, and on October 30th the 9th Circuit issued a ruling pausing Judge Winmill’s order and fully reinstating the ban pending appeal. The court’s order looked to Dobbs as binding precedent, and explained that, although the district court found that there is a history and tradition of protecting health-preserving abortions, Dobbs “plowed the same ground and held that ‘the Constitution does not confer a right to abortion,’” and it is therefore “unlikely that Dr. Seyb will be able to square the district court’s perspective with…Dobbs.” The court set a briefing schedule, and a full decision on the merits is expected sometime next year.
Trump Administration Joins Texas Medicaid Lawsuit Against Planned Parenthood:
Days after the election, the U.S. The Department of Justice filed notice of its intent to join Texas and an anonymous plaintiff in their federal False Claims Act lawsuit against Planned Parenthood. The litigation accuses Planned Parenthood affiliates of improperly collecting roughly $10 million in Medicaid reimbursements from Texas and Louisiana while state efforts to terminate the organization from the programs were paused by court orders. The plaintiffs are seeking more than $1.8 billion in total repayments, civil penalties, and fees. Planned Parenthood has maintained that the reimbursements were lawful while injunctions remained in effect, characterizing the federal intervention as another attack on health centers that provide essential reproductive care, birth control, and cancer screenings to millions of patients. Following a unanimous August ruling by the Fifth Circuit Court of Appeals allowing the litigation to resume after a nearly three-year pause, the case is now presided over by U.S. District Judge Matthew Kacsmaryk and is jointly proposed to begin trial in April 2027.
Trend and Policy Watch:
What the Election Results Mean for Reproductive Health:
Last week’s midterm elections delivered a landslide victory for Democratic candidates, who flipped both the U.S. House and Senate and won races up and down the ballot in states across the country. Although abortion access is unlikely to change immediately, the election’s implications for healthcare cannot be overstated. A new coalition of supportive attorneys general, governors, and legislators creates renewed potential for passing protective laws and defanging the bans and restrictions that remain in place.
In Texas, Iowa, Georgia, Ohio, and Kansas, pro-choice leaders will take over as attorneys general in January. While they can’t repeal abortion bans, attorneys general wield significant influence over how those laws are enforced and defended in court. Taking Texas as an example, Attorney General-Elect Nathan Johnson has already confirmed that he will discontinue former AG Ken Paxton’s practice of pursuing out-of-state shield providers who send medication abortion into Texas. He has also said that he will review all ongoing litigation, which means that Texas may withdraw from key abortion-related cases, including its lawsuits against the FDA and Planned Parenthood. Kansas may similarly shift its involvement in a case challenging access to mifepristone. Because these cases each involve other litigants, they will continue regardless of Texas or Kansas’s participation; however, losing Texas is a significant blow for the usual coalition of anti-abortion states. In addition to leading litigation against external entities, attorneys general have the authority to decide whether to defend their state’s own laws. This means that in states like Texas and Georgia, where their abortion bans are being actively litigated, a new attorney general could result in a change in the state’s positioning.
New leadership in the governors’ mansions could also bring state-level policy and appropriations changes impacting abortion. Texas again offers an instructive example—Governor-elect Gina Hinojosa is a strong pro-choice candidate who shared her own story of pregnancy loss on the campaign trail. As reported in the Texas Tribune, she will have the authority to make key appointments to bodies like the Texas Medical Board and the Texas Health and Human Services Commission. She will also have the opportunity to reevaluate programs like the Texas ‘Thriving Families’ program, which sends millions of dollars to crisis pregnancy centers (CPCs) each year. Other states facing similar political change in January can expect comparable downstream effects.
At the federal level, Democrats will soon control both the House and the Senate. Although the incoming congress will face challenges overcoming the president’s veto power, there is renewed momentum to create a framework for a truly progressive policy agenda while also working to push bipartisan bills across the finish line. We can expect to see Democrats working on issues like restoring ACA subsidies and Medicaid funding, partnering with Republican lawmakers on specific areas of shared interest, and using their subpoena power to hold administration officials accountable for unlawful actions. Behind the scenes, legal and political advocacy groups will be strategizing on the best approach to move the policy needle forward under the Trump administration while simultaneously preparing for a more ambitious agenda if presidential power changes hands in 2028.
Research Shows Abortion Pill Could be Beneficial for Breast Cancer:
Scientific studies indicate that abortion-related drugs, including mifepristone and ulipristal acetate, hold substantial promise for medical applications including preventing aggressive breast cancers and treating conditions like endometriosis and uterine fibroids. Clinical trials led by researchers in the United Kingdom and the United States have shown that these medications can block progesterone effects, relax dense breast tissue, and slow the cellular proliferation that drives tumor growth, particularly for patients with high-risk genetic mutations, like the BRCA gene mutation. However, the intersection of partisan politics and state-level abortion restrictions has chilled the progress of domestic scientific innovation. Investigators nationwide face regulatory barriers, pharmacy refusals, and funding uncertainties based on concerns that utilizing these medications will compromise trial continuity. Consequently, while countries abroad advance these therapeutic breakthroughs, American researchers warn that political interference may delay patient access to potentially life-saving innovations in reproductive healthcare and cancer prevention.

